270 related articles for article (PubMed ID: 9284427)
1. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
Kawasaki H
Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
[TBL] [Abstract][Full Text] [Related]
2. The renaissance of centrally acting antihypertensive drugs.
van Zwieten PA
J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
[TBL] [Abstract][Full Text] [Related]
3. Why imidazoline receptor modulator in the treatment of hypertension?
Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
Prichard BN; Owens CW; Graham BR
J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
[TBL] [Abstract][Full Text] [Related]
5. Centrally acting antihypertensive agents: an update.
Sica DA
J Clin Hypertens (Greenwich); 2007 May; 9(5):399-405. PubMed ID: 17485976
[TBL] [Abstract][Full Text] [Related]
6. [Centrally-acting antihypertensive drugs].
Takishita S; Yamazato M
Nihon Rinsho; 2004 Mar; 62 Suppl 3():591-5. PubMed ID: 15171442
[No Abstract] [Full Text] [Related]
7. Moxonidine: a new antiadrenergic antihypertensive agent.
Prichard BN; Graham BR; Owens CW
J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
[TBL] [Abstract][Full Text] [Related]
8. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO
Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578
[TBL] [Abstract][Full Text] [Related]
10. Relationship between imidazoline and alpha2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents.
Head GA; Chan CK; Burke SL
J Auton Nerv Syst; 1998 Oct; 72(2-3):163-9. PubMed ID: 9851565
[TBL] [Abstract][Full Text] [Related]
11. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
[TBL] [Abstract][Full Text] [Related]
12. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
[TBL] [Abstract][Full Text] [Related]
13. From alpha and beta to I1: an overview of sympathetic receptors involved in blood pressure control targets for drug treatment.
van Zwieten PA
J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S5-10. PubMed ID: 8872294
[TBL] [Abstract][Full Text] [Related]
14. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
[TBL] [Abstract][Full Text] [Related]
15. Centrally acting imidazoline I1-receptor agonists: do they have a place in the management of hypertension?
van Zwieten PA
Am J Cardiovasc Drugs; 2001; 1(5):321-6. PubMed ID: 14728014
[TBL] [Abstract][Full Text] [Related]
16. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats.
El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM
Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461
[TBL] [Abstract][Full Text] [Related]
17. Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics.
van Zwieten PA
J Hypertens Suppl; 1997 Jan; 15(1):S3-8. PubMed ID: 9050980
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats.
Wang LG; Zeng J; Yuan WJ; Su DF; Wang WZ
Exp Physiol; 2007 Sep; 92(5):849-58. PubMed ID: 17573415
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol.
Reid JL; Panfilov V; MacPhee G; Elliott HL
Ann N Y Acad Sci; 1995 Jul; 763():673-8. PubMed ID: 7677387
[TBL] [Abstract][Full Text] [Related]
20. Moxonidine: a review of safety and tolerability after seven years of clinical experience.
Schachter M
J Hypertens Suppl; 1999 Aug; 17(3):S37-9. PubMed ID: 10489097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
